Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prenatal Exposure Delayed Effects | 64 | 2025 | 563 | 14.650 |
Why?
|
Diabetes Mellitus, Type 2 | 179 | 2025 | 2430 | 14.030 |
Why?
|
Diabetes Mellitus, Type 1 | 206 | 2025 | 3624 | 13.500 |
Why?
|
Adiposity | 55 | 2024 | 504 | 13.400 |
Why?
|
Diabetes, Gestational | 39 | 2025 | 307 | 9.380 |
Why?
|
Body Mass Index | 102 | 2025 | 2261 | 8.250 |
Why?
|
Pediatric Obesity | 38 | 2025 | 570 | 8.060 |
Why?
|
Birth Weight | 44 | 2024 | 498 | 7.600 |
Why?
|
Pregnancy | 178 | 2025 | 6357 | 6.820 |
Why?
|
Body Composition | 24 | 2023 | 644 | 5.800 |
Why?
|
Child | 304 | 2025 | 20655 | 5.560 |
Why?
|
Diet | 34 | 2025 | 1199 | 5.120 |
Why?
|
Obesity | 73 | 2025 | 2858 | 4.940 |
Why?
|
Adolescent | 275 | 2025 | 20179 | 4.780 |
Why?
|
Insulin Resistance | 36 | 2024 | 1164 | 4.770 |
Why?
|
Infant, Newborn | 117 | 2025 | 5687 | 4.670 |
Why?
|
Cardiovascular Diseases | 47 | 2024 | 1999 | 4.470 |
Why?
|
Female | 422 | 2025 | 68154 | 4.450 |
Why?
|
Maternal Exposure | 21 | 2025 | 175 | 4.400 |
Why?
|
Child Development | 17 | 2025 | 452 | 4.390 |
Why?
|
Child, Preschool | 144 | 2025 | 10384 | 4.000 |
Why?
|
Humans | 529 | 2025 | 128418 | 3.870 |
Why?
|
Vascular Stiffness | 19 | 2025 | 464 | 3.780 |
Why?
|
Overnutrition | 7 | 2021 | 30 | 3.630 |
Why?
|
Non-alcoholic Fatty Liver Disease | 6 | 2023 | 258 | 3.470 |
Why?
|
Cohort Studies | 93 | 2025 | 5388 | 3.470 |
Why?
|
Male | 322 | 2025 | 62858 | 3.400 |
Why?
|
Fluorocarbons | 9 | 2024 | 109 | 3.390 |
Why?
|
Environmental Pollutants | 12 | 2025 | 142 | 3.350 |
Why?
|
Maternal Nutritional Physiological Phenomena | 13 | 2024 | 169 | 3.350 |
Why?
|
Blood Glucose | 59 | 2024 | 2093 | 3.160 |
Why?
|
Young Adult | 164 | 2025 | 12312 | 3.050 |
Why?
|
DNA Methylation | 23 | 2025 | 604 | 3.030 |
Why?
|
Breast Feeding | 16 | 2024 | 422 | 2.970 |
Why?
|
Risk Factors | 116 | 2025 | 9704 | 2.930 |
Why?
|
Tobacco Smoke Pollution | 6 | 2024 | 229 | 2.900 |
Why?
|
Diabetes Mellitus | 28 | 2025 | 1000 | 2.900 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 7 | 2021 | 59 | 2.890 |
Why?
|
Diabetic Ketoacidosis | 10 | 2024 | 197 | 2.890 |
Why?
|
Infant | 96 | 2025 | 8914 | 2.830 |
Why?
|
Fetal Blood | 20 | 2024 | 316 | 2.800 |
Why?
|
Longitudinal Studies | 53 | 2025 | 2710 | 2.800 |
Why?
|
Diabetic Angiopathies | 17 | 2025 | 262 | 2.780 |
Why?
|
Insulin | 47 | 2024 | 2315 | 2.740 |
Why?
|
Prospective Studies | 59 | 2024 | 7036 | 2.700 |
Why?
|
Food Hypersensitivity | 4 | 2024 | 173 | 2.610 |
Why?
|
Adult | 190 | 2025 | 35300 | 2.540 |
Why?
|
Biomarkers | 38 | 2025 | 3880 | 2.370 |
Why?
|
Metformin | 21 | 2025 | 312 | 2.320 |
Why?
|
Environmental Exposure | 16 | 2024 | 461 | 2.320 |
Why?
|
Mothers | 22 | 2024 | 729 | 2.290 |
Why?
|
Prevalence | 65 | 2025 | 2547 | 2.260 |
Why?
|
Abdominal Fat | 5 | 2023 | 40 | 2.200 |
Why?
|
Air Pollutants | 11 | 2024 | 312 | 2.170 |
Why?
|
Air Pollution | 9 | 2023 | 214 | 2.170 |
Why?
|
Colorado | 41 | 2024 | 4375 | 2.170 |
Why?
|
Weight Gain | 12 | 2023 | 503 | 2.160 |
Why?
|
Age of Onset | 24 | 2022 | 491 | 2.050 |
Why?
|
Plethysmography | 13 | 2022 | 107 | 2.040 |
Why?
|
Epigenesis, Genetic | 19 | 2025 | 615 | 2.020 |
Why?
|
Diabetes Complications | 11 | 2023 | 223 | 1.930 |
Why?
|
Pregnancy in Diabetics | 10 | 2018 | 118 | 1.830 |
Why?
|
Pregnancy Complications | 14 | 2024 | 487 | 1.820 |
Why?
|
Premature Birth | 11 | 2025 | 310 | 1.800 |
Why?
|
Adiponectin | 12 | 2025 | 234 | 1.800 |
Why?
|
Linear Models | 24 | 2024 | 813 | 1.780 |
Why?
|
Intra-Abdominal Fat | 6 | 2023 | 88 | 1.770 |
Why?
|
Child Health | 12 | 2025 | 146 | 1.760 |
Why?
|
Prediabetic State | 11 | 2025 | 245 | 1.730 |
Why?
|
Triglycerides | 17 | 2024 | 523 | 1.700 |
Why?
|
Feeding Behavior | 12 | 2023 | 618 | 1.670 |
Why?
|
Adipose Tissue | 11 | 2022 | 589 | 1.660 |
Why?
|
Cholesterol, LDL | 10 | 2022 | 360 | 1.640 |
Why?
|
United States | 100 | 2025 | 13830 | 1.630 |
Why?
|
Blood Pressure | 18 | 2025 | 1728 | 1.620 |
Why?
|
Asthma | 12 | 2025 | 2213 | 1.580 |
Why?
|
Cannabidiol | 2 | 2024 | 91 | 1.560 |
Why?
|
Exercise | 17 | 2025 | 1929 | 1.510 |
Why?
|
Hypoglycemic Agents | 26 | 2025 | 1212 | 1.460 |
Why?
|
Overweight | 18 | 2024 | 524 | 1.460 |
Why?
|
Dermatitis, Atopic | 3 | 2024 | 321 | 1.450 |
Why?
|
Smoking | 7 | 2019 | 1460 | 1.450 |
Why?
|
Incidence | 40 | 2025 | 2616 | 1.450 |
Why?
|
Albuminuria | 11 | 2025 | 181 | 1.450 |
Why?
|
Life Style | 21 | 2025 | 460 | 1.450 |
Why?
|
Genetic Predisposition to Disease | 22 | 2022 | 2264 | 1.430 |
Why?
|
Phthalic Acids | 7 | 2025 | 45 | 1.420 |
Why?
|
Cannabinoids | 2 | 2023 | 129 | 1.410 |
Why?
|
Dyslipidemias | 5 | 2021 | 176 | 1.410 |
Why?
|
Health Behavior | 14 | 2025 | 741 | 1.410 |
Why?
|
Fatty Liver | 4 | 2021 | 231 | 1.390 |
Why?
|
Puberty | 6 | 2024 | 142 | 1.310 |
Why?
|
Cognition | 8 | 2024 | 1107 | 1.300 |
Why?
|
Lipids | 14 | 2020 | 620 | 1.240 |
Why?
|
Follow-Up Studies | 30 | 2025 | 4892 | 1.220 |
Why?
|
Vitamin D | 6 | 2023 | 380 | 1.190 |
Why?
|
Leptin | 8 | 2021 | 218 | 1.180 |
Why?
|
Energy Metabolism | 6 | 2021 | 831 | 1.170 |
Why?
|
Insulin-Secreting Cells | 8 | 2017 | 366 | 1.140 |
Why?
|
Cross-Sectional Studies | 49 | 2025 | 5039 | 1.130 |
Why?
|
Body Weight | 12 | 2024 | 928 | 1.110 |
Why?
|
Age Factors | 32 | 2024 | 3103 | 1.090 |
Why?
|
Hyperinsulinism | 2 | 2021 | 119 | 1.080 |
Why?
|
Hypertension | 13 | 2025 | 1235 | 1.050 |
Why?
|
Adolescent Behavior | 6 | 2024 | 505 | 1.030 |
Why?
|
Indians, North American | 16 | 2022 | 600 | 1.010 |
Why?
|
Caprylates | 2 | 2023 | 22 | 1.010 |
Why?
|
Cannabis | 2 | 2023 | 429 | 1.000 |
Why?
|
Energy Intake | 6 | 2024 | 454 | 0.980 |
Why?
|
Rhinitis, Allergic | 2 | 2024 | 38 | 0.980 |
Why?
|
Autism Spectrum Disorder | 5 | 2024 | 385 | 0.960 |
Why?
|
Heart Rate | 7 | 2022 | 800 | 0.940 |
Why?
|
Anthropometry | 9 | 2022 | 204 | 0.920 |
Why?
|
Islets of Langerhans | 7 | 2021 | 790 | 0.910 |
Why?
|
Carbon Isotopes | 1 | 2024 | 123 | 0.900 |
Why?
|
Pulse Wave Analysis | 14 | 2025 | 248 | 0.890 |
Why?
|
Oxytocin | 1 | 2024 | 48 | 0.870 |
Why?
|
Calcinosis | 7 | 2023 | 230 | 0.860 |
Why?
|
Sex Factors | 18 | 2025 | 1945 | 0.860 |
Why?
|
Waist Circumference | 10 | 2019 | 138 | 0.860 |
Why?
|
Food Supply | 7 | 2024 | 72 | 0.860 |
Why?
|
Postal Service | 2 | 2016 | 33 | 0.850 |
Why?
|
Vehicle Emissions | 3 | 2021 | 56 | 0.850 |
Why?
|
Pregnancy Outcome | 7 | 2024 | 389 | 0.840 |
Why?
|
Cotinine | 3 | 2023 | 75 | 0.830 |
Why?
|
Infant, Small for Gestational Age | 4 | 2024 | 84 | 0.830 |
Why?
|
Subcutaneous Fat | 4 | 2019 | 74 | 0.830 |
Why?
|
Phenols | 5 | 2024 | 96 | 0.830 |
Why?
|
Autoantibodies | 10 | 2022 | 1463 | 0.830 |
Why?
|
Diabetic Neuropathies | 7 | 2023 | 90 | 0.810 |
Why?
|
Dronabinol | 1 | 2024 | 166 | 0.810 |
Why?
|
Immunoglobulin E | 1 | 2024 | 329 | 0.810 |
Why?
|
Hyperglycemia | 8 | 2021 | 326 | 0.800 |
Why?
|
Health Status | 5 | 2024 | 755 | 0.800 |
Why?
|
Gestational Age | 14 | 2025 | 867 | 0.780 |
Why?
|
Vitamins | 5 | 2023 | 174 | 0.770 |
Why?
|
Registries | 12 | 2021 | 1877 | 0.770 |
Why?
|
Liver | 3 | 2021 | 1826 | 0.760 |
Why?
|
HLA Antigens | 4 | 2014 | 235 | 0.760 |
Why?
|
Dietary Carbohydrates | 3 | 2019 | 151 | 0.760 |
Why?
|
Insulins | 1 | 2022 | 37 | 0.750 |
Why?
|
Inflammation | 8 | 2023 | 2654 | 0.740 |
Why?
|
Eczema | 1 | 2022 | 67 | 0.740 |
Why?
|
Lipoproteins, HDL | 3 | 2017 | 85 | 0.740 |
Why?
|
Cardiovascular System | 1 | 2023 | 137 | 0.730 |
Why?
|
Electronic Health Records | 8 | 2025 | 974 | 0.730 |
Why?
|
Hallucinogens | 1 | 2023 | 86 | 0.730 |
Why?
|
Hypersensitivity | 1 | 2024 | 249 | 0.730 |
Why?
|
Glutamate Decarboxylase | 5 | 2021 | 166 | 0.720 |
Why?
|
Vaccines | 2 | 2023 | 393 | 0.710 |
Why?
|
Polymorphism, Genetic | 6 | 2012 | 639 | 0.710 |
Why?
|
Metabolic Diseases | 2 | 2021 | 105 | 0.710 |
Why?
|
Diet Surveys | 6 | 2021 | 92 | 0.710 |
Why?
|
Motor Activity | 6 | 2015 | 668 | 0.700 |
Why?
|
Socioeconomic Factors | 19 | 2025 | 1212 | 0.700 |
Why?
|
Case-Control Studies | 24 | 2025 | 3328 | 0.690 |
Why?
|
Dietary Supplements | 6 | 2024 | 531 | 0.690 |
Why?
|
Genome-Wide Association Study | 12 | 2025 | 1336 | 0.670 |
Why?
|
Lipid Metabolism | 8 | 2024 | 491 | 0.670 |
Why?
|
Mitochondria, Muscle | 2 | 2021 | 110 | 0.670 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2024 | 397 | 0.670 |
Why?
|
Chemokines | 1 | 2021 | 221 | 0.670 |
Why?
|
Logistic Models | 18 | 2023 | 1974 | 0.670 |
Why?
|
C-Peptide | 8 | 2024 | 163 | 0.660 |
Why?
|
Diabetic Retinopathy | 5 | 2023 | 171 | 0.660 |
Why?
|
National Institute of Child Health and Human Development (U.S.) | 2 | 2016 | 9 | 0.650 |
Why?
|
Comorbidity | 6 | 2023 | 1543 | 0.650 |
Why?
|
Prenatal Care | 2 | 2023 | 273 | 0.640 |
Why?
|
Vitamin D Deficiency | 2 | 2019 | 176 | 0.640 |
Why?
|
Gastrointestinal Microbiome | 5 | 2019 | 633 | 0.630 |
Why?
|
Transition to Adult Care | 2 | 2018 | 76 | 0.630 |
Why?
|
Social Class | 6 | 2025 | 258 | 0.630 |
Why?
|
Body Height | 7 | 2024 | 192 | 0.630 |
Why?
|
Puberty, Precocious | 1 | 2018 | 14 | 0.630 |
Why?
|
Child Welfare | 2 | 2012 | 211 | 0.620 |
Why?
|
Hypertension, Pregnancy-Induced | 4 | 2025 | 68 | 0.620 |
Why?
|
Community-Institutional Relations | 2 | 2016 | 96 | 0.620 |
Why?
|
Coronary Artery Disease | 8 | 2023 | 678 | 0.620 |
Why?
|
Glucose Intolerance | 10 | 2017 | 142 | 0.620 |
Why?
|
Infant, Newborn, Diseases | 2 | 2020 | 108 | 0.610 |
Why?
|
Maternal Health | 3 | 2019 | 46 | 0.610 |
Why?
|
Metabolome | 2 | 2024 | 319 | 0.600 |
Why?
|
Adenosine Diphosphate | 2 | 2021 | 78 | 0.590 |
Why?
|
Mental Health | 3 | 2023 | 686 | 0.590 |
Why?
|
Health Promotion | 5 | 2023 | 716 | 0.580 |
Why?
|
Patient Selection | 3 | 2016 | 663 | 0.580 |
Why?
|
Child Behavior | 4 | 2025 | 236 | 0.580 |
Why?
|
Body Fluid Compartments | 1 | 2017 | 6 | 0.570 |
Why?
|
Niacin | 1 | 2017 | 19 | 0.560 |
Why?
|
Disease Progression | 15 | 2021 | 2602 | 0.560 |
Why?
|
Fasting | 11 | 2023 | 264 | 0.560 |
Why?
|
Multivariate Analysis | 14 | 2017 | 1484 | 0.550 |
Why?
|
Neurodevelopmental Disorders | 1 | 2019 | 155 | 0.550 |
Why?
|
Health Surveys | 4 | 2021 | 492 | 0.550 |
Why?
|
Alkanesulfonic Acids | 3 | 2023 | 34 | 0.550 |
Why?
|
Particulate Matter | 8 | 2023 | 245 | 0.550 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 3 | 2014 | 62 | 0.530 |
Why?
|
Self Report | 6 | 2023 | 801 | 0.530 |
Why?
|
Sex Characteristics | 2 | 2020 | 721 | 0.520 |
Why?
|
Regression Analysis | 9 | 2019 | 978 | 0.520 |
Why?
|
Autonomic Nervous System | 2 | 2013 | 75 | 0.520 |
Why?
|
Glucose Metabolism Disorders | 1 | 2016 | 11 | 0.520 |
Why?
|
Cholesterol, HDL | 5 | 2021 | 203 | 0.520 |
Why?
|
Fetal Diseases | 1 | 2017 | 156 | 0.510 |
Why?
|
Residence Characteristics | 9 | 2024 | 326 | 0.510 |
Why?
|
Diet, High-Fat | 1 | 2017 | 238 | 0.510 |
Why?
|
Healthy Lifestyle | 1 | 2016 | 32 | 0.500 |
Why?
|
Child of Impaired Parents | 2 | 2015 | 40 | 0.500 |
Why?
|
Risk Assessment | 12 | 2024 | 3232 | 0.500 |
Why?
|
Cytokines | 2 | 2021 | 1983 | 0.500 |
Why?
|
Epidemiologic Studies | 2 | 2018 | 65 | 0.490 |
Why?
|
Micronutrients | 3 | 2023 | 88 | 0.490 |
Why?
|
Predictive Value of Tests | 13 | 2021 | 1935 | 0.490 |
Why?
|
Glucose | 9 | 2023 | 982 | 0.490 |
Why?
|
Dietary Fats | 3 | 2016 | 301 | 0.490 |
Why?
|
Algorithms | 7 | 2024 | 1618 | 0.480 |
Why?
|
Dietary Proteins | 1 | 2016 | 128 | 0.480 |
Why?
|
Patient Compliance | 4 | 2016 | 560 | 0.480 |
Why?
|
Folic Acid | 6 | 2023 | 184 | 0.480 |
Why?
|
Apolipoproteins B | 5 | 2012 | 43 | 0.470 |
Why?
|
Surveys and Questionnaires | 19 | 2019 | 5362 | 0.470 |
Why?
|
Testosterone | 4 | 2024 | 373 | 0.470 |
Why?
|
Television | 3 | 2015 | 74 | 0.460 |
Why?
|
Metabolic Syndrome | 5 | 2021 | 338 | 0.460 |
Why?
|
Mental Recall | 3 | 2021 | 184 | 0.460 |
Why?
|
Fatty Acids, Omega-3 | 4 | 2024 | 137 | 0.460 |
Why?
|
Smoking Cessation | 1 | 2018 | 408 | 0.460 |
Why?
|
Risk Reduction Behavior | 3 | 2017 | 209 | 0.450 |
Why?
|
Creatinine | 4 | 2016 | 475 | 0.450 |
Why?
|
Parabens | 2 | 2024 | 12 | 0.450 |
Why?
|
Odds Ratio | 10 | 2023 | 1023 | 0.450 |
Why?
|
Transcription Factor 7-Like 2 Protein | 2 | 2011 | 22 | 0.450 |
Why?
|
Vaccination | 1 | 2022 | 1346 | 0.440 |
Why?
|
Physical Fitness | 2 | 2012 | 203 | 0.440 |
Why?
|
Diabetic Cardiomyopathies | 1 | 2014 | 34 | 0.440 |
Why?
|
Maternal-Fetal Exchange | 1 | 2015 | 161 | 0.430 |
Why?
|
Homeostasis | 4 | 2021 | 603 | 0.430 |
Why?
|
Infant, Low Birth Weight | 4 | 2024 | 135 | 0.420 |
Why?
|
Muscle Cells | 2 | 2017 | 39 | 0.420 |
Why?
|
Vitamin A | 2 | 2023 | 55 | 0.420 |
Why?
|
Stress, Psychological | 5 | 2025 | 1060 | 0.410 |
Why?
|
Risk | 8 | 2024 | 853 | 0.410 |
Why?
|
Retrospective Studies | 18 | 2023 | 14454 | 0.410 |
Why?
|
Adolescent Development | 1 | 2013 | 82 | 0.410 |
Why?
|
Ohio | 6 | 2015 | 153 | 0.410 |
Why?
|
Glucose Tolerance Test | 8 | 2021 | 356 | 0.400 |
Why?
|
Vegetables | 5 | 2023 | 147 | 0.400 |
Why?
|
Time Factors | 13 | 2022 | 6482 | 0.390 |
Why?
|
Nutrition Policy | 4 | 2023 | 56 | 0.390 |
Why?
|
Femoral Artery | 1 | 2013 | 170 | 0.390 |
Why?
|
Pandemics | 8 | 2023 | 1476 | 0.390 |
Why?
|
Fatty Acids, Nonesterified | 4 | 2022 | 159 | 0.390 |
Why?
|
Placenta | 4 | 2023 | 716 | 0.390 |
Why?
|
Carotid Arteries | 1 | 2013 | 195 | 0.390 |
Why?
|
Calcium | 8 | 2023 | 1178 | 0.380 |
Why?
|
Data Collection | 4 | 2022 | 647 | 0.380 |
Why?
|
Prognosis | 6 | 2021 | 3772 | 0.380 |
Why?
|
Proportional Hazards Models | 11 | 2022 | 1196 | 0.380 |
Why?
|
Autistic Disorder | 3 | 2024 | 185 | 0.380 |
Why?
|
Magnetic Resonance Imaging | 6 | 2021 | 3376 | 0.370 |
Why?
|
Pre-Eclampsia | 2 | 2024 | 185 | 0.370 |
Why?
|
Autoimmunity | 6 | 2021 | 860 | 0.360 |
Why?
|
Maternal Age | 4 | 2021 | 123 | 0.360 |
Why?
|
Arteries | 2 | 2010 | 262 | 0.360 |
Why?
|
Diabetic Nephropathies | 6 | 2020 | 278 | 0.360 |
Why?
|
Sugars | 2 | 2023 | 37 | 0.360 |
Why?
|
Nutrition Assessment | 2 | 2021 | 85 | 0.360 |
Why?
|
Down-Regulation | 1 | 2013 | 631 | 0.360 |
Why?
|
Hydrocortisone | 2 | 2025 | 304 | 0.360 |
Why?
|
Self Concept | 1 | 2012 | 242 | 0.350 |
Why?
|
Middle Aged | 42 | 2025 | 30889 | 0.350 |
Why?
|
Population Surveillance | 6 | 2016 | 427 | 0.350 |
Why?
|
Geographic Information Systems | 2 | 2012 | 40 | 0.350 |
Why?
|
Pesticides | 2 | 2022 | 58 | 0.350 |
Why?
|
Public Health | 2 | 2023 | 482 | 0.350 |
Why?
|
Respiratory Sounds | 2 | 2021 | 120 | 0.340 |
Why?
|
Bayes Theorem | 5 | 2023 | 369 | 0.340 |
Why?
|
DNA Helicases | 1 | 2012 | 149 | 0.340 |
Why?
|
Educational Status | 4 | 2025 | 470 | 0.340 |
Why?
|
Fatty Acids | 4 | 2024 | 415 | 0.340 |
Why?
|
Cesarean Section | 1 | 2012 | 182 | 0.340 |
Why?
|
Arsenic | 2 | 2023 | 66 | 0.330 |
Why?
|
Metabolomics | 4 | 2024 | 599 | 0.330 |
Why?
|
Eating | 6 | 2023 | 368 | 0.330 |
Why?
|
Fetal Growth Retardation | 2 | 2023 | 543 | 0.320 |
Why?
|
Gene-Environment Interaction | 2 | 2021 | 185 | 0.320 |
Why?
|
Minority Groups | 6 | 2023 | 251 | 0.320 |
Why?
|
Alleles | 6 | 2021 | 844 | 0.320 |
Why?
|
Lipoproteins | 2 | 2016 | 171 | 0.320 |
Why?
|
Diet, Mediterranean | 2 | 2022 | 29 | 0.310 |
Why?
|
Fetal Development | 4 | 2019 | 283 | 0.310 |
Why?
|
Hypoglycemia | 3 | 2024 | 425 | 0.310 |
Why?
|
Adipogenesis | 3 | 2023 | 49 | 0.300 |
Why?
|
Precision Medicine | 3 | 2023 | 384 | 0.290 |
Why?
|
Hunger | 2 | 2019 | 38 | 0.290 |
Why?
|
CpG Islands | 6 | 2024 | 152 | 0.290 |
Why?
|
Analysis of Variance | 5 | 2018 | 1269 | 0.280 |
Why?
|
Soot | 2 | 2024 | 25 | 0.280 |
Why?
|
South Carolina | 4 | 2012 | 41 | 0.280 |
Why?
|
Executive Function | 2 | 2025 | 422 | 0.280 |
Why?
|
American Heart Association | 2 | 2023 | 298 | 0.280 |
Why?
|
Weight Loss | 5 | 2021 | 725 | 0.280 |
Why?
|
Depression | 6 | 2024 | 1296 | 0.280 |
Why?
|
Cost of Illness | 1 | 2009 | 277 | 0.270 |
Why?
|
Phenol | 2 | 2023 | 19 | 0.270 |
Why?
|
Mass Screening | 5 | 2020 | 1147 | 0.270 |
Why?
|
Microvessels | 2 | 2019 | 79 | 0.260 |
Why?
|
Diet Records | 4 | 2021 | 80 | 0.260 |
Why?
|
Treatment Outcome | 12 | 2020 | 10152 | 0.260 |
Why?
|
Benzhydryl Compounds | 2 | 2024 | 66 | 0.260 |
Why?
|
C-Reactive Protein | 5 | 2019 | 397 | 0.260 |
Why?
|
Body Size | 2 | 2020 | 101 | 0.260 |
Why?
|
Peripheral Vascular Diseases | 2 | 2019 | 102 | 0.260 |
Why?
|
Blood Glucose Self-Monitoring | 6 | 2023 | 601 | 0.260 |
Why?
|
Weight Reduction Programs | 2 | 2017 | 111 | 0.260 |
Why?
|
Causality | 2 | 2020 | 116 | 0.260 |
Why?
|
Carotid Intima-Media Thickness | 3 | 2017 | 90 | 0.260 |
Why?
|
Hepatocyte Nuclear Factor 4 | 2 | 2017 | 14 | 0.250 |
Why?
|
Health Services Accessibility | 4 | 2020 | 896 | 0.250 |
Why?
|
Internet | 1 | 2010 | 617 | 0.250 |
Why?
|
Epigenomics | 3 | 2025 | 110 | 0.250 |
Why?
|
Coronary Disease | 3 | 2007 | 382 | 0.240 |
Why?
|
Phenotype | 10 | 2025 | 3044 | 0.240 |
Why?
|
Protective Factors | 3 | 2021 | 91 | 0.240 |
Why?
|
Retinal Diseases | 2 | 2023 | 86 | 0.240 |
Why?
|
Polymorphism, Single Nucleotide | 8 | 2023 | 2062 | 0.230 |
Why?
|
Insurance, Health | 3 | 2023 | 267 | 0.230 |
Why?
|
Beverages | 2 | 2015 | 67 | 0.230 |
Why?
|
Fetal Macrosomia | 2 | 2018 | 62 | 0.230 |
Why?
|
Health | 2 | 2015 | 73 | 0.230 |
Why?
|
Denmark | 2 | 2023 | 44 | 0.230 |
Why?
|
Menarche | 2 | 2018 | 58 | 0.220 |
Why?
|
Social Segregation | 1 | 2023 | 2 | 0.220 |
Why?
|
Chlorophenols | 1 | 2023 | 8 | 0.220 |
Why?
|
Diethylhexyl Phthalate | 1 | 2024 | 15 | 0.220 |
Why?
|
Benzophenones | 1 | 2023 | 16 | 0.220 |
Why?
|
Polyneuropathies | 1 | 2024 | 51 | 0.220 |
Why?
|
Parturition | 2 | 2022 | 70 | 0.220 |
Why?
|
Pregnancy Trimester, Second | 3 | 2021 | 78 | 0.220 |
Why?
|
AMP-Activated Protein Kinases | 3 | 2024 | 190 | 0.220 |
Why?
|
Lead | 1 | 2024 | 56 | 0.220 |
Why?
|
Rubella | 1 | 2023 | 23 | 0.220 |
Why?
|
Mumps | 1 | 2023 | 24 | 0.210 |
Why?
|
Circadian Clocks | 1 | 2023 | 42 | 0.210 |
Why?
|
Vulnerable Populations | 1 | 2024 | 157 | 0.210 |
Why?
|
Appetite | 1 | 2023 | 57 | 0.210 |
Why?
|
HLA-DQ beta-Chains | 3 | 2019 | 61 | 0.210 |
Why?
|
Measles | 1 | 2023 | 44 | 0.210 |
Why?
|
Preconception Care | 1 | 2023 | 39 | 0.210 |
Why?
|
Chickenpox | 1 | 2023 | 78 | 0.210 |
Why?
|
Parents | 6 | 2022 | 1304 | 0.210 |
Why?
|
India | 2 | 2020 | 170 | 0.200 |
Why?
|
HLA-DRB1 Chains | 3 | 2019 | 108 | 0.200 |
Why?
|
Psychological Tests | 1 | 2023 | 132 | 0.200 |
Why?
|
Cholesterol | 4 | 2023 | 406 | 0.200 |
Why?
|
Food Assistance | 1 | 2023 | 29 | 0.200 |
Why?
|
Societies, Medical | 4 | 2022 | 745 | 0.200 |
Why?
|
Endocrine Disruptors | 2 | 2024 | 40 | 0.200 |
Why?
|
Population Health | 1 | 2023 | 46 | 0.200 |
Why?
|
Polychlorinated Biphenyls | 1 | 2022 | 9 | 0.200 |
Why?
|
Nutritional Status | 4 | 2018 | 325 | 0.200 |
Why?
|
Child Nutritional Physiological Phenomena | 2 | 2013 | 104 | 0.200 |
Why?
|
Reference Values | 5 | 2012 | 776 | 0.200 |
Why?
|
Breast Neoplasms | 2 | 2011 | 2132 | 0.200 |
Why?
|
Drinking Water | 1 | 2023 | 74 | 0.200 |
Why?
|
Subcutaneous Fat, Abdominal | 1 | 2022 | 13 | 0.190 |
Why?
|
Hydrocarbons, Chlorinated | 1 | 2022 | 21 | 0.190 |
Why?
|
Satiation | 2 | 2023 | 23 | 0.190 |
Why?
|
Vascular Calcification | 1 | 2023 | 107 | 0.190 |
Why?
|
Kidney Diseases | 2 | 2023 | 367 | 0.190 |
Why?
|
Starch | 1 | 2022 | 22 | 0.190 |
Why?
|
Umbilical Cord | 3 | 2017 | 84 | 0.190 |
Why?
|
Pregnancy Proteins | 1 | 2022 | 37 | 0.190 |
Why?
|
Quality of Life | 8 | 2024 | 2680 | 0.190 |
Why?
|
Cognitive Dysfunction | 2 | 2023 | 343 | 0.190 |
Why?
|
Poverty | 5 | 2025 | 496 | 0.190 |
Why?
|
Cortisone | 1 | 2021 | 10 | 0.190 |
Why?
|
Ozone | 1 | 2022 | 103 | 0.190 |
Why?
|
RNA, Ribosomal, 16S | 3 | 2018 | 519 | 0.190 |
Why?
|
Age Distribution | 3 | 2019 | 371 | 0.190 |
Why?
|
Patient Education as Topic | 4 | 2018 | 737 | 0.190 |
Why?
|
Treatment Adherence and Compliance | 1 | 2021 | 23 | 0.190 |
Why?
|
Pregnanolone | 1 | 2021 | 27 | 0.180 |
Why?
|
Arizona | 6 | 2000 | 78 | 0.180 |
Why?
|
Endotoxins | 1 | 2022 | 216 | 0.180 |
Why?
|
Tobacco Products | 1 | 2022 | 110 | 0.180 |
Why?
|
Autonomic Nervous System Diseases | 2 | 2019 | 34 | 0.180 |
Why?
|
Allergens | 1 | 2024 | 383 | 0.180 |
Why?
|
Health Services, Indigenous | 1 | 2021 | 34 | 0.180 |
Why?
|
Food | 1 | 2022 | 155 | 0.180 |
Why?
|
Allostasis | 1 | 2021 | 16 | 0.180 |
Why?
|
Membrane Proteins | 3 | 2021 | 1105 | 0.180 |
Why?
|
Immunization Schedule | 1 | 2022 | 198 | 0.180 |
Why?
|
11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2021 | 9 | 0.180 |
Why?
|
Mitogen-Activated Protein Kinase 9 | 1 | 2021 | 18 | 0.180 |
Why?
|
Macular Degeneration | 1 | 2023 | 157 | 0.180 |
Why?
|
Glycation End Products, Advanced | 1 | 2021 | 72 | 0.180 |
Why?
|
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2021 | 41 | 0.180 |
Why?
|
Lipase | 1 | 2021 | 64 | 0.180 |
Why?
|
Calcium, Dietary | 4 | 2023 | 56 | 0.180 |
Why?
|
Latent Autoimmune Diabetes in Adults | 1 | 2020 | 2 | 0.180 |
Why?
|
Muscle, Skeletal | 3 | 2021 | 1627 | 0.180 |
Why?
|
Klinefelter Syndrome | 1 | 2021 | 56 | 0.180 |
Why?
|
Pregnancy Trimesters | 2 | 2025 | 16 | 0.180 |
Why?
|
Nutrition Surveys | 5 | 2024 | 261 | 0.180 |
Why?
|
Epidemiological Monitoring | 1 | 2021 | 49 | 0.180 |
Why?
|
Slovenia | 1 | 2020 | 1 | 0.170 |
Why?
|
Phospholipids | 2 | 2019 | 207 | 0.170 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2021 | 126 | 0.170 |
Why?
|
Depression, Postpartum | 1 | 2022 | 128 | 0.170 |
Why?
|
Immunoglobulin G | 2 | 2022 | 843 | 0.170 |
Why?
|
Fibrinogen | 4 | 2019 | 158 | 0.170 |
Why?
|
Observational Studies as Topic | 1 | 2021 | 108 | 0.170 |
Why?
|
Genetic Markers | 1 | 2021 | 338 | 0.170 |
Why?
|
Gene Expression | 3 | 2023 | 1456 | 0.170 |
Why?
|
Immunization | 1 | 2022 | 412 | 0.170 |
Why?
|
Pregnancy Trimester, Third | 2 | 2018 | 107 | 0.170 |
Why?
|
Brachial Artery | 2 | 2013 | 190 | 0.170 |
Why?
|
Germany | 1 | 2020 | 97 | 0.170 |
Why?
|
Nervous System Diseases | 1 | 2023 | 252 | 0.170 |
Why?
|
Chromosome Mapping | 1 | 2021 | 504 | 0.170 |
Why?
|
Potassium Channels, Inwardly Rectifying | 2 | 2012 | 31 | 0.170 |
Why?
|
Depressive Disorder | 1 | 2023 | 360 | 0.170 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2021 | 269 | 0.170 |
Why?
|
Progesterone | 1 | 2021 | 242 | 0.170 |
Why?
|
Sexual and Gender Minorities | 1 | 2023 | 193 | 0.160 |
Why?
|
Aged | 13 | 2025 | 21953 | 0.160 |
Why?
|
Thioctic Acid | 1 | 1999 | 7 | 0.160 |
Why?
|
Healthcare Disparities | 3 | 2023 | 579 | 0.160 |
Why?
|
Waist-Height Ratio | 1 | 2019 | 7 | 0.160 |
Why?
|
Dehydroepiandrosterone | 1 | 2019 | 51 | 0.160 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2021 | 508 | 0.160 |
Why?
|
Principal Component Analysis | 1 | 2019 | 183 | 0.160 |
Why?
|
Research Design | 2 | 2023 | 1036 | 0.160 |
Why?
|
Infant, Premature | 2 | 2023 | 535 | 0.160 |
Why?
|
Demography | 1 | 2020 | 277 | 0.160 |
Why?
|
Ventricular Remodeling | 1 | 2021 | 254 | 0.160 |
Why?
|
Sleep Wake Disorders | 1 | 2022 | 250 | 0.160 |
Why?
|
HLA-D Antigens | 1 | 2019 | 34 | 0.160 |
Why?
|
Diagnostic Techniques, Endocrine | 1 | 2018 | 14 | 0.150 |
Why?
|
Guideline Adherence | 2 | 2014 | 521 | 0.150 |
Why?
|
Luteinizing Hormone | 1 | 2019 | 178 | 0.150 |
Why?
|
Lipopolysaccharides | 1 | 2022 | 856 | 0.150 |
Why?
|
Sexual Maturation | 1 | 2018 | 52 | 0.150 |
Why?
|
Genetic Variation | 2 | 2021 | 933 | 0.150 |
Why?
|
Reproducibility of Results | 4 | 2021 | 3020 | 0.150 |
Why?
|
Atrial Fibrillation | 1 | 2023 | 377 | 0.150 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2021 | 307 | 0.150 |
Why?
|
Patient Reported Outcome Measures | 1 | 2022 | 368 | 0.150 |
Why?
|
Multicenter Studies as Topic | 2 | 2016 | 285 | 0.150 |
Why?
|
Echocardiography | 1 | 2021 | 623 | 0.150 |
Why?
|
Family | 2 | 2023 | 651 | 0.150 |
Why?
|
Apolipoproteins A | 2 | 1995 | 19 | 0.150 |
Why?
|
Glomerular Filtration Rate | 2 | 2020 | 681 | 0.150 |
Why?
|
Mutation | 3 | 2022 | 3689 | 0.150 |
Why?
|
Exome | 1 | 2019 | 220 | 0.150 |
Why?
|
Self Efficacy | 2 | 2018 | 374 | 0.150 |
Why?
|
Epidemiologic Research Design | 1 | 2018 | 28 | 0.150 |
Why?
|
Pediatrics | 3 | 2018 | 1046 | 0.150 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2018 | 43 | 0.150 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2021 | 383 | 0.150 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2023 | 375 | 0.150 |
Why?
|
PPAR gamma | 2 | 2016 | 182 | 0.140 |
Why?
|
Patient Acceptance of Health Care | 3 | 2023 | 758 | 0.140 |
Why?
|
Ventricular Function, Left | 1 | 2021 | 524 | 0.140 |
Why?
|
Family Characteristics | 3 | 2023 | 179 | 0.140 |
Why?
|
Glucokinase | 2 | 2017 | 13 | 0.140 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 2 | 2017 | 16 | 0.140 |
Why?
|
Endocrinology | 1 | 2018 | 74 | 0.140 |
Why?
|
Trans Fatty Acids | 1 | 2017 | 6 | 0.140 |
Why?
|
Phosphorus Isotopes | 1 | 2017 | 7 | 0.140 |
Why?
|
Skinfold Thickness | 2 | 2020 | 46 | 0.140 |
Why?
|
Brain | 2 | 2020 | 2620 | 0.140 |
Why?
|
Coronary Vessels | 4 | 2023 | 236 | 0.140 |
Why?
|
Granuloma | 1 | 2017 | 84 | 0.140 |
Why?
|
Fear | 1 | 2020 | 325 | 0.140 |
Why?
|
Cystatin C | 1 | 2017 | 65 | 0.140 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2017 | 51 | 0.140 |
Why?
|
Rheumatoid Factor | 1 | 2018 | 168 | 0.140 |
Why?
|
Pilot Projects | 6 | 2023 | 1564 | 0.140 |
Why?
|
History, 21st Century | 1 | 2018 | 181 | 0.140 |
Why?
|
Awards and Prizes | 1 | 2018 | 62 | 0.140 |
Why?
|
Anti-Citrullinated Protein Antibodies | 1 | 2018 | 111 | 0.140 |
Why?
|
Needs Assessment | 3 | 2016 | 359 | 0.140 |
Why?
|
Animals | 11 | 2024 | 34479 | 0.140 |
Why?
|
Leisure Activities | 1 | 2016 | 29 | 0.130 |
Why?
|
Feeding and Eating Disorders | 1 | 2019 | 144 | 0.130 |
Why?
|
Genome, Human | 1 | 2019 | 391 | 0.130 |
Why?
|
History, 20th Century | 1 | 2018 | 291 | 0.130 |
Why?
|
Gastrointestinal Tract | 1 | 2019 | 182 | 0.130 |
Why?
|
Reward | 1 | 2019 | 240 | 0.130 |
Why?
|
Combined Modality Therapy | 3 | 2015 | 1204 | 0.130 |
Why?
|
Dietary Fiber | 2 | 2014 | 49 | 0.130 |
Why?
|
Exercise Therapy | 2 | 2017 | 413 | 0.130 |
Why?
|
Postpartum Period | 1 | 2019 | 330 | 0.130 |
Why?
|
Insurance Coverage | 1 | 2018 | 220 | 0.130 |
Why?
|
Language | 1 | 2019 | 281 | 0.130 |
Why?
|
Gonadal Steroid Hormones | 1 | 2017 | 129 | 0.130 |
Why?
|
Genomics | 1 | 2021 | 715 | 0.130 |
Why?
|
Oxidative Phosphorylation | 1 | 2017 | 184 | 0.130 |
Why?
|
Mexico | 2 | 2011 | 190 | 0.130 |
Why?
|
Blood Pressure Determination | 1 | 2017 | 148 | 0.130 |
Why?
|
Vitamin B 12 | 1 | 2016 | 122 | 0.130 |
Why?
|
Niacinamide | 1 | 2016 | 73 | 0.130 |
Why?
|
Genetic Testing | 1 | 2019 | 428 | 0.130 |
Why?
|
Carbon | 3 | 2023 | 207 | 0.130 |
Why?
|
Evidence-Based Medicine | 2 | 2023 | 711 | 0.130 |
Why?
|
Motivational Interviewing | 1 | 2017 | 97 | 0.130 |
Why?
|
Choristoma | 1 | 2015 | 21 | 0.120 |
Why?
|
Antioxidants | 1 | 1999 | 538 | 0.120 |
Why?
|
Nutrition Therapy | 2 | 2013 | 31 | 0.120 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 230 | 0.120 |
Why?
|
Haplotypes | 2 | 2019 | 471 | 0.120 |
Why?
|
Apolipoprotein A-I | 1 | 1995 | 28 | 0.120 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2015 | 79 | 0.120 |
Why?
|
Thyroiditis, Autoimmune | 1 | 2015 | 15 | 0.120 |
Why?
|
Polyendocrinopathies, Autoimmune | 1 | 2015 | 18 | 0.120 |
Why?
|
Sulfonylurea Receptors | 2 | 2012 | 5 | 0.120 |
Why?
|
Emigrants and Immigrants | 3 | 2012 | 122 | 0.120 |
Why?
|
Feces | 1 | 2018 | 435 | 0.120 |
Why?
|
Bacteria | 2 | 2018 | 808 | 0.120 |
Why?
|
Cognition Disorders | 1 | 2019 | 497 | 0.120 |
Why?
|
Myocardial Infarction | 1 | 2022 | 1015 | 0.120 |
Why?
|
Phylogeny | 1 | 2018 | 838 | 0.120 |
Why?
|
Cluster Analysis | 3 | 2013 | 478 | 0.120 |
Why?
|
Resilience, Psychological | 1 | 2016 | 123 | 0.120 |
Why?
|
Genotype | 6 | 2023 | 1828 | 0.120 |
Why?
|
Personal Satisfaction | 1 | 2016 | 198 | 0.120 |
Why?
|
Consensus | 3 | 2023 | 613 | 0.110 |
Why?
|
Microbiota | 2 | 2019 | 719 | 0.110 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 1002 | 0.110 |
Why?
|
Interleukin-6 | 3 | 2019 | 716 | 0.110 |
Why?
|
Computers | 1 | 2014 | 65 | 0.110 |
Why?
|
Carbonated Beverages | 2 | 2011 | 16 | 0.110 |
Why?
|
Seafood | 2 | 2024 | 27 | 0.110 |
Why?
|
Global Health | 3 | 2025 | 327 | 0.110 |
Why?
|
Muscle Strength | 1 | 2017 | 305 | 0.110 |
Why?
|
Vasculitis | 1 | 2014 | 59 | 0.110 |
Why?
|
Rural Population | 1 | 2018 | 511 | 0.110 |
Why?
|
beta Catenin | 1 | 2015 | 219 | 0.110 |
Why?
|
Proteinuria | 1 | 1994 | 88 | 0.110 |
Why?
|
Family Health | 1 | 2015 | 196 | 0.110 |
Why?
|
Nutritional Requirements | 2 | 2021 | 77 | 0.110 |
Why?
|
Fishes | 2 | 2024 | 93 | 0.110 |
Why?
|
Romania | 5 | 2001 | 12 | 0.110 |
Why?
|
SEER Program | 2 | 2011 | 206 | 0.110 |
Why?
|
Muscle Development | 3 | 2021 | 103 | 0.110 |
Why?
|
Tissue Plasminogen Activator | 1 | 2015 | 219 | 0.110 |
Why?
|
Sleep | 3 | 2024 | 676 | 0.100 |
Why?
|
Managed Care Programs | 1 | 2013 | 133 | 0.100 |
Why?
|
Cation Transport Proteins | 1 | 2014 | 129 | 0.100 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2017 | 817 | 0.100 |
Why?
|
Transients and Migrants | 1 | 2012 | 25 | 0.100 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2014 | 137 | 0.100 |
Why?
|
Guidelines as Topic | 1 | 2014 | 260 | 0.100 |
Why?
|
Body Constitution | 1 | 2012 | 53 | 0.100 |
Why?
|
Insulin, Regular, Human | 2 | 2022 | 42 | 0.100 |
Why?
|
DNA | 1 | 2019 | 1390 | 0.100 |
Why?
|
Medicare | 2 | 2023 | 715 | 0.100 |
Why?
|
Statistics, Nonparametric | 4 | 2017 | 418 | 0.100 |
Why?
|
HLA-DP beta-Chains | 1 | 2012 | 84 | 0.100 |
Why?
|
Europe | 2 | 2011 | 359 | 0.100 |
Why?
|
Autoimmune Diseases | 2 | 2017 | 423 | 0.100 |
Why?
|
Intracellular Space | 1 | 2012 | 70 | 0.100 |
Why?
|
Mammary Glands, Human | 1 | 2012 | 64 | 0.100 |
Why?
|
DNA-Binding Proteins | 1 | 2019 | 1421 | 0.100 |
Why?
|
Preventive Health Services | 1 | 2013 | 145 | 0.100 |
Why?
|
Pregnant Women | 2 | 2023 | 114 | 0.090 |
Why?
|
Thinness | 1 | 2012 | 90 | 0.090 |
Why?
|
Morphogenesis | 1 | 2012 | 156 | 0.090 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2015 | 360 | 0.090 |
Why?
|
Beryllium | 1 | 2012 | 153 | 0.090 |
Why?
|
Proinsulin | 1 | 2011 | 52 | 0.090 |
Why?
|
Amine Oxidase (Copper-Containing) | 1 | 2010 | 5 | 0.090 |
Why?
|
Iron | 2 | 2023 | 282 | 0.090 |
Why?
|
Lung Diseases | 1 | 2017 | 715 | 0.090 |
Why?
|
Chronic Disease | 5 | 2022 | 1705 | 0.090 |
Why?
|
Lactation | 1 | 2012 | 170 | 0.090 |
Why?
|
Photography | 2 | 2021 | 97 | 0.090 |
Why?
|
Mexican Americans | 1 | 2012 | 113 | 0.090 |
Why?
|
Diet, Diabetic | 1 | 2011 | 35 | 0.090 |
Why?
|
E-Selectin | 1 | 2010 | 53 | 0.090 |
Why?
|
Diet, Sodium-Restricted | 1 | 2011 | 36 | 0.090 |
Why?
|
Voluntary Health Agencies | 2 | 2000 | 5 | 0.090 |
Why?
|
Dietary Sucrose | 1 | 2011 | 48 | 0.090 |
Why?
|
Sweetening Agents | 1 | 2011 | 38 | 0.090 |
Why?
|
Self Care | 1 | 2013 | 368 | 0.090 |
Why?
|
Insulin Antibodies | 1 | 2011 | 105 | 0.090 |
Why?
|
Milk, Human | 1 | 2012 | 148 | 0.090 |
Why?
|
Tandem Mass Spectrometry | 2 | 2025 | 449 | 0.090 |
Why?
|
Metabolic Equivalent | 1 | 2010 | 3 | 0.090 |
Why?
|
HLA-DR Antigens | 2 | 2009 | 224 | 0.090 |
Why?
|
Berylliosis | 1 | 2012 | 188 | 0.090 |
Why?
|
Polymerase Chain Reaction | 2 | 2016 | 1020 | 0.090 |
Why?
|
Signal Transduction | 2 | 2022 | 4826 | 0.090 |
Why?
|
Topography, Medical | 1 | 2010 | 11 | 0.080 |
Why?
|
Genetic Association Studies | 3 | 2021 | 361 | 0.080 |
Why?
|
Video Games | 1 | 2010 | 22 | 0.080 |
Why?
|
Glycosuria | 1 | 2009 | 8 | 0.080 |
Why?
|
World Health Organization | 2 | 2000 | 110 | 0.080 |
Why?
|
Glucose Clamp Technique | 1 | 2010 | 194 | 0.080 |
Why?
|
Pulsatile Flow | 1 | 2010 | 59 | 0.080 |
Why?
|
Hypolipidemic Agents | 1 | 2010 | 93 | 0.080 |
Why?
|
Cell Adhesion Molecules | 1 | 2010 | 172 | 0.080 |
Why?
|
Stochastic Processes | 1 | 2009 | 66 | 0.080 |
Why?
|
Exercise Test | 1 | 2012 | 613 | 0.080 |
Why?
|
Arthritis, Rheumatoid | 1 | 2018 | 1104 | 0.080 |
Why?
|
Arm | 1 | 2010 | 107 | 0.080 |
Why?
|
Mortality | 1 | 2011 | 307 | 0.080 |
Why?
|
Elasticity | 1 | 2010 | 199 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 853 | 0.080 |
Why?
|
Models, Theoretical | 2 | 2025 | 542 | 0.080 |
Why?
|
Limit of Detection | 2 | 2021 | 55 | 0.080 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 511 | 0.080 |
Why?
|
Menopause | 1 | 2011 | 291 | 0.080 |
Why?
|
Genetic Carrier Screening | 1 | 2008 | 25 | 0.070 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2022 | 380 | 0.070 |
Why?
|
Blood Flow Velocity | 1 | 2010 | 409 | 0.070 |
Why?
|
Reproductive History | 1 | 2008 | 18 | 0.070 |
Why?
|
Endothelium, Vascular | 1 | 2014 | 847 | 0.070 |
Why?
|
Feasibility Studies | 3 | 2017 | 860 | 0.070 |
Why?
|
Leg | 1 | 2010 | 240 | 0.070 |
Why?
|
Pregnancy in Adolescence | 1 | 2008 | 81 | 0.070 |
Why?
|
Health Personnel | 1 | 2013 | 644 | 0.070 |
Why?
|
Cell Differentiation | 3 | 2023 | 1900 | 0.070 |
Why?
|
Forecasting | 1 | 2009 | 358 | 0.070 |
Why?
|
HLA-DQ Antigens | 1 | 2008 | 179 | 0.070 |
Why?
|
International Classification of Diseases | 2 | 2021 | 123 | 0.070 |
Why?
|
Receptors, Drug | 1 | 2007 | 13 | 0.070 |
Why?
|
Models, Statistical | 1 | 2011 | 621 | 0.070 |
Why?
|
Vascular Diseases | 1 | 2010 | 232 | 0.070 |
Why?
|
Health Status Disparities | 2 | 2024 | 254 | 0.070 |
Why?
|
Quality of Health Care | 1 | 2011 | 606 | 0.070 |
Why?
|
Contraception | 1 | 2008 | 151 | 0.060 |
Why?
|
Potassium Channels | 1 | 2007 | 144 | 0.060 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2007 | 130 | 0.060 |
Why?
|
Diet, Reducing | 2 | 2017 | 86 | 0.060 |
Why?
|
Phosphorylation | 2 | 2021 | 1681 | 0.060 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2006 | 45 | 0.060 |
Why?
|
Oxidation-Reduction | 2 | 2021 | 1001 | 0.060 |
Why?
|
Transcription Factors | 2 | 2024 | 1628 | 0.060 |
Why?
|
Databases, Factual | 1 | 2011 | 1269 | 0.060 |
Why?
|
Aged, 80 and over | 3 | 2012 | 7033 | 0.060 |
Why?
|
Sex Distribution | 3 | 2019 | 358 | 0.060 |
Why?
|
Seasons | 2 | 2023 | 497 | 0.060 |
Why?
|
Gene Frequency | 2 | 2019 | 504 | 0.060 |
Why?
|
Homeodomain Proteins | 2 | 2021 | 490 | 0.060 |
Why?
|
Cause of Death | 2 | 2021 | 393 | 0.060 |
Why?
|
Interviews as Topic | 1 | 2008 | 715 | 0.060 |
Why?
|
Isoenzymes | 1 | 2006 | 304 | 0.060 |
Why?
|
Abdominal Wall | 1 | 2004 | 23 | 0.060 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2006 | 168 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2018 | 484 | 0.060 |
Why?
|
Lysine | 1 | 2007 | 278 | 0.060 |
Why?
|
Patient Participation | 1 | 2008 | 410 | 0.060 |
Why?
|
Meta-Analysis as Topic | 1 | 2025 | 169 | 0.060 |
Why?
|
Monte Carlo Method | 1 | 2024 | 137 | 0.060 |
Why?
|
Esters | 1 | 2024 | 74 | 0.060 |
Why?
|
ARNTL Transcription Factors | 1 | 2023 | 16 | 0.060 |
Why?
|
Appetitive Behavior | 1 | 2023 | 8 | 0.050 |
Why?
|
Censuses | 1 | 2023 | 27 | 0.050 |
Why?
|
Early Diagnosis | 2 | 2015 | 234 | 0.050 |
Why?
|
Netherlands | 1 | 2023 | 77 | 0.050 |
Why?
|
Appetite Regulation | 1 | 2023 | 26 | 0.050 |
Why?
|
Organophosphates | 1 | 2024 | 120 | 0.050 |
Why?
|
Academic Success | 1 | 2023 | 26 | 0.050 |
Why?
|
Alkanesulfonates | 1 | 2023 | 7 | 0.050 |
Why?
|
Mitochondria | 2 | 2021 | 848 | 0.050 |
Why?
|
Child Care | 1 | 2023 | 26 | 0.050 |
Why?
|
Carboxylic Acids | 1 | 2023 | 32 | 0.050 |
Why?
|
Environmental Health | 1 | 2023 | 37 | 0.050 |
Why?
|
Hypertrophy | 1 | 2023 | 115 | 0.050 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2005 | 371 | 0.050 |
Why?
|
Remission Induction | 1 | 2004 | 268 | 0.050 |
Why?
|
Autoantigens | 1 | 2006 | 416 | 0.050 |
Why?
|
Environment Design | 1 | 2023 | 26 | 0.050 |
Why?
|
Uric Acid | 1 | 2024 | 160 | 0.050 |
Why?
|
Magnesium | 1 | 2023 | 150 | 0.050 |
Why?
|
Sample Size | 1 | 2023 | 115 | 0.050 |
Why?
|
Gender Identity | 1 | 2023 | 121 | 0.050 |
Why?
|
Communicable Disease Control | 1 | 2023 | 70 | 0.050 |
Why?
|
Ascorbic Acid | 1 | 2023 | 120 | 0.050 |
Why?
|
Dichlorodiphenyl Dichloroethylene | 1 | 2022 | 4 | 0.050 |
Why?
|
Diagnosis, Differential | 2 | 2018 | 1416 | 0.050 |
Why?
|
Social Stigma | 1 | 2024 | 118 | 0.050 |
Why?
|
Africa, Northern | 1 | 2021 | 4 | 0.050 |
Why?
|
Sodium | 1 | 2023 | 205 | 0.050 |
Why?
|
Memory, Short-Term | 1 | 2025 | 256 | 0.050 |
Why?
|
Middle East | 1 | 2021 | 11 | 0.050 |
Why?
|
Coronary Angiography | 1 | 2004 | 306 | 0.050 |
Why?
|
Cytosine | 1 | 2022 | 46 | 0.050 |
Why?
|
Tobacco Smoking | 1 | 2022 | 25 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 4 | 2004 | 2523 | 0.050 |
Why?
|
Delivery of Health Care | 2 | 2023 | 895 | 0.050 |
Why?
|
Adipocytes | 1 | 2023 | 204 | 0.050 |
Why?
|
Guanine | 1 | 2022 | 76 | 0.050 |
Why?
|
Carcinogenesis | 1 | 2023 | 209 | 0.050 |
Why?
|
Phosphocreatine | 1 | 2021 | 40 | 0.050 |
Why?
|
Disease Susceptibility | 2 | 2015 | 331 | 0.050 |
Why?
|
Adolescent Health | 1 | 2022 | 39 | 0.050 |
Why?
|
Isomerism | 1 | 2021 | 48 | 0.050 |
Why?
|
Metabolic Flux Analysis | 1 | 2021 | 7 | 0.050 |
Why?
|
Amino Acid Substitution | 2 | 2012 | 281 | 0.050 |
Why?
|
KCNQ1 Potassium Channel | 1 | 2021 | 7 | 0.050 |
Why?
|
Receptor, Melanocortin, Type 4 | 1 | 2021 | 14 | 0.050 |
Why?
|
Mutation, Missense | 2 | 2017 | 315 | 0.050 |
Why?
|
Phosphates | 1 | 2022 | 168 | 0.040 |
Why?
|
Diastole | 1 | 2021 | 148 | 0.040 |
Why?
|
Epidemiologic Methods | 2 | 2013 | 73 | 0.040 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2023 | 528 | 0.040 |
Why?
|
Antihypertensive Agents | 1 | 2005 | 485 | 0.040 |
Why?
|
Protein Interaction Mapping | 1 | 2021 | 107 | 0.040 |
Why?
|
Australia | 1 | 2021 | 245 | 0.040 |
Why?
|
Maternal Inheritance | 1 | 2020 | 15 | 0.040 |
Why?
|
Cell-Free Nucleic Acids | 1 | 2021 | 31 | 0.040 |
Why?
|
Drug Discovery | 1 | 2021 | 130 | 0.040 |
Why?
|
Metabolic Networks and Pathways | 1 | 2021 | 175 | 0.040 |
Why?
|
Confidence Intervals | 3 | 2008 | 316 | 0.040 |
Why?
|
Fathers | 1 | 2000 | 48 | 0.040 |
Why?
|
Western World | 1 | 2019 | 6 | 0.040 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2021 | 475 | 0.040 |
Why?
|
Community Health Services | 1 | 2021 | 226 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2014 | 2722 | 0.040 |
Why?
|
Endoplasmic Reticulum Stress | 1 | 2020 | 101 | 0.040 |
Why?
|
Schools | 1 | 2023 | 438 | 0.040 |
Why?
|
Asymptomatic Diseases | 1 | 2019 | 84 | 0.040 |
Why?
|
HLA-DQ alpha-Chains | 1 | 2019 | 15 | 0.040 |
Why?
|
Heart | 1 | 2023 | 635 | 0.040 |
Why?
|
Hyperphagia | 1 | 2019 | 33 | 0.040 |
Why?
|
Adenosine Triphosphate | 1 | 2021 | 471 | 0.040 |
Why?
|
In Vitro Techniques | 1 | 2021 | 1039 | 0.040 |
Why?
|
Norway | 1 | 2018 | 42 | 0.040 |
Why?
|
Social Support | 1 | 2023 | 589 | 0.040 |
Why?
|
Sexual Behavior | 1 | 2023 | 481 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2016 | 1815 | 0.040 |
Why?
|
Health Services Research | 1 | 2021 | 391 | 0.040 |
Why?
|
Insulin Infusion Systems | 1 | 2022 | 362 | 0.040 |
Why?
|
Environmental Monitoring | 1 | 2021 | 322 | 0.040 |
Why?
|
Hospitalization | 1 | 2008 | 2057 | 0.040 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 385 | 0.040 |
Why?
|
Walking | 1 | 2023 | 494 | 0.040 |
Why?
|
Environmental Pollution | 1 | 2018 | 18 | 0.040 |
Why?
|
Pregnancy Trimester, First | 1 | 2018 | 138 | 0.040 |
Why?
|
International Cooperation | 1 | 2018 | 171 | 0.040 |
Why?
|
Software | 1 | 2023 | 608 | 0.040 |
Why?
|
Fruit | 2 | 2011 | 131 | 0.040 |
Why?
|
Bifidobacterium | 1 | 2017 | 21 | 0.040 |
Why?
|
Acetyl-CoA Carboxylase | 1 | 2017 | 33 | 0.040 |
Why?
|
Hepatocyte Nuclear Factor 1-beta | 1 | 2017 | 4 | 0.040 |
Why?
|
Genes, rRNA | 1 | 2017 | 41 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 1356 | 0.040 |
Why?
|
Electron Transport | 1 | 2017 | 112 | 0.040 |
Why?
|
Ganglionectomy | 1 | 1997 | 2 | 0.030 |
Why?
|
Carnitine | 1 | 2017 | 76 | 0.030 |
Why?
|
Carnitine O-Palmitoyltransferase | 1 | 2017 | 45 | 0.030 |
Why?
|
DNA, Bacterial | 1 | 2018 | 323 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2008 | 1901 | 0.030 |
Why?
|
Mitochondrial Diseases | 1 | 2017 | 88 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 2018 | 272 | 0.030 |
Why?
|
Immunoglobulin A | 1 | 2018 | 201 | 0.030 |
Why?
|
ROC Curve | 2 | 2013 | 500 | 0.030 |
Why?
|
Thoracoscopy | 1 | 1997 | 50 | 0.030 |
Why?
|
Birth Rate | 1 | 2016 | 25 | 0.030 |
Why?
|
Sirtuin 1 | 1 | 2016 | 30 | 0.030 |
Why?
|
Clinical Coding | 1 | 2016 | 20 | 0.030 |
Why?
|
Accelerometry | 1 | 2016 | 91 | 0.030 |
Why?
|
Primary Prevention | 1 | 2017 | 185 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2017 | 580 | 0.030 |
Why?
|
Glycogen Synthase Kinase 3 beta | 1 | 2015 | 67 | 0.030 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2015 | 43 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2019 | 641 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2016 | 145 | 0.030 |
Why?
|
Decision Support Techniques | 1 | 2019 | 396 | 0.030 |
Why?
|
Ankle Brachial Index | 1 | 2015 | 36 | 0.030 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2015 | 45 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2017 | 751 | 0.030 |
Why?
|
Palmitic Acid | 1 | 2015 | 40 | 0.030 |
Why?
|
Linoleic Acid | 1 | 2015 | 40 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 1046 | 0.030 |
Why?
|
Trans-Activators | 1 | 2017 | 381 | 0.030 |
Why?
|
CTLA-4 Antigen | 1 | 2015 | 89 | 0.030 |
Why?
|
International Agencies | 1 | 2014 | 29 | 0.030 |
Why?
|
Focus Groups | 1 | 2017 | 452 | 0.030 |
Why?
|
Fatty Acid Desaturases | 1 | 2015 | 32 | 0.030 |
Why?
|
Fetus | 1 | 2019 | 760 | 0.030 |
Why?
|
Vitamin E | 1 | 2015 | 118 | 0.030 |
Why?
|
Linkage Disequilibrium | 1 | 2015 | 256 | 0.030 |
Why?
|
CD40 Antigens | 1 | 2015 | 88 | 0.030 |
Why?
|
Mice | 2 | 2023 | 16602 | 0.030 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2014 | 33 | 0.030 |
Why?
|
Societies, Scientific | 1 | 2014 | 46 | 0.030 |
Why?
|
RNA, Messenger | 1 | 2022 | 2675 | 0.030 |
Why?
|
Medication Adherence | 1 | 2019 | 560 | 0.030 |
Why?
|
Carbohydrates | 1 | 2014 | 62 | 0.030 |
Why?
|
Adolescent Medicine | 1 | 2014 | 36 | 0.030 |
Why?
|
Physical Endurance | 1 | 2015 | 264 | 0.030 |
Why?
|
Sampling Studies | 1 | 2014 | 96 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2017 | 518 | 0.030 |
Why?
|
Estradiol | 1 | 2017 | 486 | 0.030 |
Why?
|
Amino Acids | 1 | 2017 | 474 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 815 | 0.030 |
Why?
|
Biopsy | 1 | 2017 | 1081 | 0.030 |
Why?
|
Forearm | 1 | 2014 | 117 | 0.030 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2013 | 49 | 0.030 |
Why?
|
Zinc Transporter 8 | 1 | 2014 | 86 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2015 | 196 | 0.030 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2013 | 36 | 0.030 |
Why?
|
Population Groups | 1 | 2013 | 58 | 0.030 |
Why?
|
Eicosapentaenoic Acid | 1 | 2013 | 36 | 0.030 |
Why?
|
Population Growth | 1 | 2012 | 9 | 0.030 |
Why?
|
Program Evaluation | 1 | 2017 | 874 | 0.030 |
Why?
|
Informed Consent | 1 | 2014 | 168 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2014 | 1275 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 993 | 0.030 |
Why?
|
Docosahexaenoic Acids | 1 | 2013 | 83 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2019 | 2755 | 0.020 |
Why?
|
Treatment Failure | 1 | 2013 | 339 | 0.020 |
Why?
|
Static Electricity | 1 | 2012 | 117 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2014 | 459 | 0.020 |
Why?
|
Respiratory Hypersensitivity | 1 | 2012 | 65 | 0.020 |
Why?
|
Placebos | 1 | 2012 | 201 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2013 | 384 | 0.020 |
Why?
|
Hot Temperature | 1 | 2014 | 358 | 0.020 |
Why?
|
Athletes | 1 | 2015 | 409 | 0.020 |
Why?
|
Milk | 1 | 2012 | 119 | 0.020 |
Why?
|
Atherosclerosis | 1 | 2015 | 403 | 0.020 |
Why?
|
Mammary Glands, Animal | 1 | 2012 | 124 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 1936 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2017 | 1176 | 0.020 |
Why?
|
Administration, Oral | 1 | 2013 | 754 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2012 | 302 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 1688 | 0.020 |
Why?
|
Small-Area Analysis | 1 | 2010 | 9 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2012 | 803 | 0.020 |
Why?
|
Practice Patterns, Physicians' | 1 | 2018 | 1258 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2015 | 817 | 0.020 |
Why?
|
Fetal Weight | 1 | 2009 | 56 | 0.020 |
Why?
|
Skin | 1 | 2014 | 718 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2012 | 495 | 0.020 |
Why?
|
Intestines | 1 | 2012 | 344 | 0.020 |
Why?
|
Gravidity | 1 | 2008 | 7 | 0.020 |
Why?
|
Coitus | 1 | 2008 | 25 | 0.020 |
Why?
|
Probability | 1 | 2009 | 305 | 0.020 |
Why?
|
Women's Health | 1 | 2011 | 362 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 2505 | 0.020 |
Why?
|
Psychology, Adolescent | 1 | 2008 | 63 | 0.020 |
Why?
|
Cross-Cultural Comparison | 1 | 2008 | 82 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2009 | 283 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2015 | 4001 | 0.020 |
Why?
|
Risk-Taking | 1 | 2010 | 347 | 0.020 |
Why?
|
Anti-Asthmatic Agents | 1 | 2011 | 371 | 0.020 |
Why?
|
Contraception Behavior | 1 | 2008 | 97 | 0.020 |
Why?
|
Counseling | 1 | 2010 | 382 | 0.020 |
Why?
|
Fertility | 1 | 2008 | 160 | 0.020 |
Why?
|
Bias | 1 | 2008 | 195 | 0.020 |
Why?
|
Contraceptive Agents, Female | 1 | 2008 | 78 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2015 | 1923 | 0.020 |
Why?
|
Hemodynamics | 1 | 2012 | 1081 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2008 | 264 | 0.020 |
Why?
|
Protein Binding | 1 | 2012 | 2103 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2008 | 555 | 0.020 |
Why?
|
Biomedical Research | 1 | 2012 | 635 | 0.020 |
Why?
|
Waist-Hip Ratio | 1 | 2004 | 35 | 0.010 |
Why?
|
Attitude to Health | 1 | 2008 | 431 | 0.010 |
Why?
|
Radiography, Abdominal | 1 | 2004 | 44 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2008 | 1848 | 0.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2011 | 945 | 0.010 |
Why?
|
Primary Health Care | 1 | 2014 | 1670 | 0.010 |
Why?
|
Models, Biological | 1 | 2009 | 1691 | 0.010 |
Why?
|
Thoracoscopes | 1 | 1997 | 2 | 0.010 |
Why?
|
Thromboangiitis Obliterans | 1 | 1997 | 2 | 0.010 |
Why?
|